乳腺浸润性导管症,breast invasive ductal cancer
1)breast invasive ductal cancer乳腺浸润性导管症
2)breast invasive ductal carcinoma乳腺浸润性导管癌
1.The different study of the expression of TSP,MVD and erbB4 gene inbreast invasive ductal carcinoma between Han and Uygur;维吾尔族和汉族乳腺浸润性导管癌TSP、MVD、erbB4表达的差异
2.Expression of Ets-1 and VEGF inbreast invasive ductal carcinoma and its clinical significanceEts-1、VEGF在乳腺浸润性导管癌组织的表达及其临床意义
3.Objective: To investigate the expression of pituitary tumor transfor-ming gene (PTTG), matrix metalloproteinase-14 (MMP-14) and vascular endothelial growth factor-C (VEGF-C) in humanbreast invasive ductal carcinoma.目的：检测乳腺浸润性导管癌与乳腺良性病变组织中垂体瘤转化基因(PTTG)，基质金属蛋白酶-14(MMP-14)和血管内皮生长因子-C(VEGF-C)的表达，探讨它们与乳腺浸润性导管癌淋巴结转移的关系及其临床病理意义。
英文短句/例句
1.The irregular mass lesion seen here is an infiltrating ductal carcinoma of breast.不规则块状病变是乳腺浸润性导管癌。
2.Expressions of CD24 in Breast Invasive Ductal Carcinoma;CD24在乳腺浸润性导管癌中表达的研究
3.The Diagnostic Experience in Image of Ninty-six Breast Infiltrating Ductal Carcinoma乳腺浸润性导管癌96例影像诊断体会
4.Analysis of the factors related to prognosis of breast invasive ductal carcinoma乳腺浸润性导管癌预后相关因素分析
5.Expression of PTTG and COX2 in Breast Invasive Ductal Carcinoma and Their Clinical Significance;乳腺浸润性导管癌PTTG及COX2的表达及临床意义
6.Expressions and clinical significance of maspin and uPA in breast cancer乳腺浸润性导管癌中Maspin、uPA的表达及其临床意义
7.Relationship Between Expression of ΔNp73 and Prognosis of Invasive Breast Duct Carcinoma乳腺浸润性导管癌中ΔNp73的表达与预后的关系
8.Expression of HPV16,18E6 and MCM7 proteins in mammary invasive duct carcinomas乳腺浸润性导管癌组织中HPV16、18E6及MCM7蛋白的表达
9.Expression of miR-125b and its clinical significance in invasive ductal carcinoma of the breast cancer乳腺浸润性导管癌中miR-125b的表达及其临床意义
10.Expression of Let-7c in invasive ductal carcinoma of breast cancer and its clinical significanceLet-7c在乳腺浸润性导管癌中的表达及临床意义
11.Expression and clinical significance of EphB4 in breast infiltrating ductal carcinoma:report of 65 casesEphB4在乳腺浸润性导管癌中的表达及意义
12.Study on Angiogenesis in Breast Invasive Ductal Carcinoma and Intraductal Proliferative Lesion;乳腺浸润性导管癌和导管内增生性病变中血管生成的研究
13.Expression and significance of GnRHR in breast invasive duct carcinoma乳腺浸润性导管癌中促性腺激素释放激素受体的表达及意义
14.Study of the Relationship of PDGF-B and PDGFR-α Expression between the Density of Microvessel and Lymphatic Vessel in Breast Infiltrating Ductal Carcinoma;乳腺浸润性导管癌中PDGF-B、PDGFR-α的表达与微血管、淋巴管密度的关系
15.Expression and significance of cyclooxygenase-2 and vascular endothelial growth factor in invasive ductal carcinoma(IDC) of breast乳腺浸润性导管癌血管内皮生长因子和环氧化酶-2的表达及意义
16.A nest of metastatic infiltrating ductal carcinoma from breast is seen in a dilated lymphatic channel in the lung.肺扩张的淋巴管可见来自乳腺浸润性导管癌转移灶。
17.Role of Transcription Factors Ets1 and Stat3 in Regulating Angiogenesis in Breast Infiltrating Ductal Carcinoma;转录因子Ets1和Stat3在乳腺浸润性导管癌中对血管生成的调控作用
18.Relationship between Tumor Angiogenesis and Transcription Factor Ets1 in Breast Infiltrating Ductal Carcinoma乳腺浸润性导管癌微血管生成与转录因子Ets1表达之间的关系
相关短句/例句
breast invasive ductal carcinoma乳腺浸润性导管癌
1.The different study of the expression of TSP,MVD and erbB4 gene inbreast invasive ductal carcinoma between Han and Uygur;维吾尔族和汉族乳腺浸润性导管癌TSP、MVD、erbB4表达的差异
2.Expression of Ets-1 and VEGF inbreast invasive ductal carcinoma and its clinical significanceEts-1、VEGF在乳腺浸润性导管癌组织的表达及其临床意义
3.Objective: To investigate the expression of pituitary tumor transfor-ming gene (PTTG), matrix metalloproteinase-14 (MMP-14) and vascular endothelial growth factor-C (VEGF-C) in humanbreast invasive ductal carcinoma.目的：检测乳腺浸润性导管癌与乳腺良性病变组织中垂体瘤转化基因(PTTG)，基质金属蛋白酶-14(MMP-14)和血管内皮生长因子-C(VEGF-C)的表达，探讨它们与乳腺浸润性导管癌淋巴结转移的关系及其临床病理意义。
3)breast infiltrating ductal carcinoma乳腺浸润性导管癌
1.Expression of C-erbB-2 in humanbreast infiltrating ductal carcinoma and its implication;C-erbB-2在乳腺浸润性导管癌中的表达及意义
2.Objective: To investigate the expressions of presenilin-2 (PS2) and glutathione S transferase π (GSTπ) and their roles in prognosis and therapy ofbreast infiltrating ductal carcinoma.目的了解乳腺浸润性导管癌中雌激素调节蛋白(PS2)和谷胱甘肽S-转移酶π(GSTπ)的表达及其对预后和治疗的指导作用。
3.Methods Formalin-fixed, paraffin-embedded tissues of 30 cases of breast usual ductal hyperplasia (UDH), 30 cases of breast atypical ductal hyperplasia (ADH) and 36 cases ofbreast infiltrating ductal carcinoma (IDC) were detected by immunohistochemistry assay using monoclonal antibodies of TSG101, MDM2 and ER.方法 采用免疫组织化学方法检测30例乳腺普通型导管增生(UDH)、30例乳腺不典型导管增生(ADH)以及36例乳腺浸润性导管癌(IDC)石蜡包埋组织中TSG101、MDM2及ER蛋白的表达水平，应用SPSS10。
4)invasive ductal carcinoma乳腺浸润性导管癌
1.Expression and significance of Maspin and p53 ininvasive ductal carcinoma;Maspin、p53在乳腺浸润性导管癌中的表达及其意义
2.Objective:To study the expression of PPARγ and PTEN in intraductal proliferative lesions,invasive ductal carcinoma and analyze the influence of breast cancer.(3)PPARγ和PTEN在乳腺浸润性导管癌中的阳性表达呈负相关(r=-0。
5)invasive ductual breast carcinoma浸润性乳腺导管癌
6)invasive ductal carcinoma of breast乳腺浸润性导管癌
1.Objective: To investigate the expression and their correlation of BCRP、HIF-1a and HER-2 ininvasive ductal carcinoma of breast,to elucidate their relationships with clinicopathologic Parameters,ER/PR status,and Disease Free Survival Time in human breast cancer.目的:通过检测乳腺浸润性导管癌组织中BCRP、HIF-1a、HER-2的表达,探讨其相关性,分析三者与乳腺癌临床病理特征、雌、孕激素受体表达情况的关系及对患者无瘤生存期的影响,为优化乳腺癌的化学治疗、预测疗效提供参考依据。
2.Objectives To investigate the expressions of BCRP,HIF-1α and HER-2 and their correlation ininvasive ductal carcinoma of breast,so as to elucidate their relationship with breast cancer clinicoPathologic Parameters.目的探讨乳腺浸润性导管癌组织中乳腺癌耐药蛋白(BCRP)、缺氧诱导因子-1α(HIF-1α)、人类表皮生长因子受体-2(HER-2)的表达及临床意义。
延伸阅读
乳腺乳腺指乳房内的腺叶。乳房内有15～20个以乳头为中心呈辐射状排列的腺叶。每个腺叶内含有腺泡及导管(输乳管)，叶间由结缔组织间隔，导管开口于乳头。乳腺小叶间质中有纤维束，将胸腺管与胸肌筋膜及真皮紧密相连。
